Potential of Boronic Acid Derivatization and Activity in Agrochemical Discovery.

Since the approval of Bortezomib (Velcade) by the U.S. Food and Drug Administration (FDA) in 2003, boron-containing drugs have successfully entered the global market, spanning therapeutic areas such as anticancer, antibacterial, and antifungal agents.